Cysteinyl leukotrienes and collagen type I synthesis in asthma.
Akihiro
A
Nomura
Takahide
T
Kodama
Yuko
Y
Morishima
Yukio
Y
Ishii
Tohru
T
Sakamoto
Toru
T
Kimura
Kiyohisa
K
Sekizawa
D000085:Acetates / Q000494:pharmacology; D000328:Adult; D000730:Androstadienes / Q000494:pharmacology; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001249:Asthma / Q000188:drug therapy / Q000276:immunology*; D024042:Collagen Type I / Q000096:biosynthesis* / Q000187:drug effects / Q000276:immunology; D003521:Cyclopropanes; D004804:Eosinophils / Q000276:immunology; D005260:Female; D000068298:Fluticasone; D006801:Humans; D020024:Leukotriene Antagonists / Q000494:pharmacology; D008297:Male; D008565:Membrane Proteins / Q000096:biosynthesis* / Q000187:drug effects / Q000276:immunology; D008875:Middle Aged; D010446:Peptide Fragments / Q000187:drug effects / Q000276:immunology; D010865:Pilot Projects; D011347:Procollagen / Q000096:biosynthesis* / Q000187:drug effects / Q000276:immunology; D011804:Quinolines / Q000494:pharmacology; D018077:Receptors, Leukotriene / Q000096:biosynthesis* / Q000187:drug effects / Q000276:immunology; D013183:Sputum / Q000737:chemistry / Q000276:immunology; D013440:Sulfides
D000085:Acetates; D000730:Androstadienes; D000893:Anti-Inflammatory Agents; D024042:Collagen Type I; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D008565:Membrane Proteins; D010446:Peptide Fragments; D011347:Procollagen; D011804:Quinolines; D018077:Receptors, Leukotriene; D013440:Sulfides; C042813:procollagen type I carboxy terminal peptide; D000068298:Fluticasone; C083169:leukotriene D4 receptor; C093875:montelukast